Lisa Beatty1,2, Emma Kemp3,4, Joseph R Coll3, Jane Turner5, Phyllis Butow6, Donna Milne7, Patsy Yates8, Sylvie Lambert9, Addie Wootten10, Desmond Yip11,12, Bogda Koczwara3,4. 1. Flinders University, GPO Box 2100, Adelaide, SA, 5001, Australia. lisa.beatty@flinders.edu.au. 2. Flinders Centre for Innovation in Cancer, Adelaide, Australia. lisa.beatty@flinders.edu.au. 3. Flinders University, GPO Box 2100, Adelaide, SA, 5001, Australia. 4. Flinders Centre for Innovation in Cancer, Adelaide, Australia. 5. Mental Health Centre, The University of Queensland, Herston, Australia. 6. University of Sydney, Sydney, New South Wales, Australia. 7. Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. 8. Queensland University of Technology, Brisbane, Queensland, Australia. 9. Ingram School of Nursing, McGill University, Wilson Hall, 3506 University Street, Montreal, H3A 2A7, Canada. 10. Smiling Mind, Abbotsford, Victoria, Australia. 11. Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia. 12. ANU Medical School, Australian National University, Acton, ACT, Australia.
Abstract
PURPOSE: This multicentre randomised controlled trial examined the efficacy of Finding My Way (FMW), a 6-week/6-module online self-guided psychotherapeutic intervention for newly diagnosed curatively treated cancer survivors, in reducing cancer-related distress and improving quality of life compared to an online attention control. METHODS: Participants were randomised on a 1:1 ratio using a gender-stratified block design to intervention (n = 94) or attention control (n = 97), and were blinded to condition. Assessments were completed at baseline (T0), post-intervention (T1), 3 months (T2), and 6 months (T3) post-intervention. Mixed model repeated measures analyses examined differences between groups for cancer-specific distress (primary outcome) and general distress, quality of life (QoL), coping, and health service utilisation (secondary outcomes). RESULTS: While both groups reported reduced cancer-specific and general distress over time, between-group differences were not significant. Intervention participants reported lower total health service utilisation and supportive care utilisation post-intervention than controls (total HS use: between-group mean difference = - 1.07 (- 1.85 to - 0.28); supportive care use: between-group mean difference = - 0.64 (- 1.21 to - 0.06)) and significantly higher emotional functioning at 3 months (between-group mean difference = 7.04 (0.15 to 13.9)). At 6 months, the supportive care utilisation finding reversed (between-group mean difference = 0.78 points (0.19 to 1.37). Across remaining QoL and coping outcomes, no significant group differences emerged. CONCLUSIONS: While both groups experienced reductions in distress, between-group differences were not significant. This contrasts with the significantly improved emotional functioning observed in FMW participants at 3 months and the short-term reductions in health service utilisation. Long-term increases in supportive care service utilisation suggest FMW only met needs while being actively used. TRIAL REGISTRATION: ACTRN12613000001796; http://www.ANZCTR.org.au/ACTRN12613000001796.aspx.
RCT Entities:
PURPOSE: This multicentre randomised controlled trial examined the efficacy of Finding My Way (FMW), a 6-week/6-module online self-guided psychotherapeutic intervention for newly diagnosed curatively treated cancer survivors, in reducing cancer-related distress and improving quality of life compared to an online attention control. METHODS:Participants were randomised on a 1:1 ratio using a gender-stratified block design to intervention (n = 94) or attention control (n = 97), and were blinded to condition. Assessments were completed at baseline (T0), post-intervention (T1), 3 months (T2), and 6 months (T3) post-intervention. Mixed model repeated measures analyses examined differences between groups for cancer-specific distress (primary outcome) and general distress, quality of life (QoL), coping, and health service utilisation (secondary outcomes). RESULTS: While both groups reported reduced cancer-specific and general distress over time, between-group differences were not significant. Intervention participants reported lower total health service utilisation and supportive care utilisation post-intervention than controls (total HS use: between-group mean difference = - 1.07 (- 1.85 to - 0.28); supportive care use: between-group mean difference = - 0.64 (- 1.21 to - 0.06)) and significantly higher emotional functioning at 3 months (between-group mean difference = 7.04 (0.15 to 13.9)). At 6 months, the supportive care utilisation finding reversed (between-group mean difference = 0.78 points (0.19 to 1.37). Across remaining QoL and coping outcomes, no significant group differences emerged. CONCLUSIONS: While both groups experienced reductions in distress, between-group differences were not significant. This contrasts with the significantly improved emotional functioning observed in FMW participants at 3 months and the short-term reductions in health service utilisation. Long-term increases in supportive care service utilisation suggest FMW only met needs while being actively used. TRIAL REGISTRATION: ACTRN12613000001796; http://www.ANZCTR.org.au/ACTRN12613000001796.aspx.
Entities:
Keywords:
Acute survivorship; CBT; Distress; Internet intervention; RCT; Self-guided
Authors: Angeliki Tsiouris; Anna Mayer; Charlotte Nölke; Christian Ruckes; Nicole Labitzke; Jörg Wiltink; Manfred E Beutel; Rüdiger Zwerenz Journal: Internet Interv Date: 2021-06-08
Authors: Lisa Beatty; Emma Kemp; Jane Turner; Phyllis Butow; Donna Milne; Patsy Yates; Sylvie Lambert; Addie Wootten; Bogda Koczwara Journal: Support Care Cancer Date: 2021-06-17 Impact factor: 3.603
Authors: Robin M Lally; Kevin A Kupzyk; Gina Bellavia; Jennifer Hydeman; Steven Gallo; Vicki S Helgeson; Deborah Erwin; Adam C Mills; Jean K Brown Journal: Support Care Cancer Date: 2019-08-14 Impact factor: 3.603
Authors: Sylvie D Lambert; Lindsay R Duncan; S Nicole Culos-Reed; Laura Hallward; Celestia S Higano; Ekaterina Loban; Anne Katz; Manon De Raad; Janet Ellis; Melissa B Korman; Carly Sears; Cindy Ibberson; Lauren Walker; Eric Belzile; Paramita Saha-Chaudhuri; Helen McTaggart-Cowan; Stuart Peacock Journal: Curr Oncol Date: 2022-02-01 Impact factor: 3.677